OBJECTIVE: To investigate whether the presence of autoantibodies specific for type 1 diabetes (T1D) is determined by the major genetic susceptibility locus for the disease at the HLA genes, using the T1D Genetics Consortium data. METHODS: We analysed anti-IA-2 and anti-GAD 65 autoantibody data from 2282 T1D patients from 1117 multiplex families. HLA genotyping was available for all cases and their parents and association with autoantibody positivity was tested by the transmission disequilibrium test. RESULTS: Association of anti-IA-2 with the HLA genes was detected at high statistical significance. HLA-DRB1*0401 confers both the strongest type 1 diabetes risk, and positive association of anti-IA-2, whereas the DRB1*03- DQA1*0501-DQB1*0201 haplotype, associated less strongly with T1D, showed a significant negative association with anti-IA-2 positivity. Interestingly, HLA-A*24 is also negatively associated with anti-IA-2, independently of the DRB1*03- DQA1*0501-DQB1*0201 haplotype. No statistically significant association was identified between anti-GAD65 and HLA. CONCLUSIONS: This study highlights that IA-2 as an autoantigen depends on HLA genotype and suggests new insights into the mechanism of loss of immune tolerance.
OBJECTIVE: To investigate whether the presence of autoantibodies specific for type 1 diabetes (T1D) is determined by the major genetic susceptibility locus for the disease at the HLA genes, using the T1D Genetics Consortium data. METHODS: We analysed anti-IA-2 and anti-GAD 65 autoantibody data from 2282 T1D patients from 1117 multiplex families. HLA genotyping was available for all cases and their parents and association with autoantibody positivity was tested by the transmission disequilibrium test. RESULTS: Association of anti-IA-2 with the HLA genes was detected at high statistical significance. HLA-DRB1*0401 confers both the strongest type 1 diabetes risk, and positive association of anti-IA-2, whereas the DRB1*03- DQA1*0501-DQB1*0201 haplotype, associated less strongly with T1D, showed a significant negative association with anti-IA-2 positivity. Interestingly, HLA-A*24 is also negatively associated with anti-IA-2, independently of the DRB1*03- DQA1*0501-DQB1*0201 haplotype. No statistically significant association was identified between anti-GAD65 and HLA. CONCLUSIONS: This study highlights that IA-2 as an autoantigen depends on HLA genotype and suggests new insights into the mechanism of loss of immune tolerance.
Authors: Jinko Graham; William A Hagopian; Ingrid Kockum; Lou Sheng Li; Carani B Sanjeevi; Robert M Lowe; Jonathan B Schaefer; Marjan Zarghami; Heather L Day; Mona Landin-Olsson; Jerry P Palmer; Marta Janer-Villanueva; Leroy Hood; Göran Sundkvist; Ake Lernmark; Norman Breslow; Gisela Dahlquist; Göran Blohmé Journal: Diabetes Date: 2002-05 Impact factor: 9.461
Authors: A J K Williams; R J Aitken; M A-M Chandler; K M Gillespie; V Lampasona; P J Bingley Journal: Diabetologia Date: 2008-05-27 Impact factor: 10.122
Authors: C Andrew Stewart; Roger Horton; Richard J N Allcock; Jennifer L Ashurst; Alexey M Atrazhev; Penny Coggill; Ian Dunham; Simon Forbes; Karen Halls; Joanna M M Howson; Sean J Humphray; Sarah Hunt; Andrew J Mungall; Kazutoyo Osoegawa; Sophie Palmer; Anne N Roberts; Jane Rogers; Sarah Sims; Yu Wang; Laurens G Wilming; John F Elliott; Pieter J de Jong; Stephen Sawcer; John A Todd; John Trowsdale; Stephan Beck Journal: Genome Res Date: 2004-05-12 Impact factor: 9.043
Authors: S Genovese; R Bonfanti; E Bazzigaluppi; V Lampasona; E Benazzi; E Bosi; G Chiumello; E Bonifacio Journal: Diabetologia Date: 1996-10 Impact factor: 10.122
Authors: L I Alves; E Davini; M R Correia; R T Fukui; R F Santos; M R Cunha; D M Rocha; W M G Volpini; M E R Silva Journal: J Clin Immunol Date: 2012-03-09 Impact factor: 8.317
Authors: Ezio Bonifacio; Liping Yu; Alastair K Williams; George S Eisenbarth; Polly J Bingley; Santica M Marcovina; Kerstin Adler; Anette G Ziegler; Patricia W Mueller; Desmond A Schatz; Jeffrey P Krischer; Michael W Steffes; Beena Akolkar Journal: J Clin Endocrinol Metab Date: 2010-05-05 Impact factor: 5.958
Authors: Vincent Plagnol; Joanna M M Howson; Deborah J Smyth; Neil Walker; Jason P Hafler; Chris Wallace; Helen Stevens; Laura Jackson; Matthew J Simmonds; Polly J Bingley; Stephen C Gough; John A Todd Journal: PLoS Genet Date: 2011-08-04 Impact factor: 5.917
Authors: Tomer Hertz; Christine M Oshansky; Philippa L Roddam; John P DeVincenzo; Miguela A Caniza; Nebojsa Jojic; Simon Mallal; Elizabeth Phillips; Ian James; M Elizabeth Halloran; Paul G Thomas; Lawrence Corey Journal: Proc Natl Acad Sci U S A Date: 2013-07-22 Impact factor: 11.205
Authors: Joanna M M Howson; Helen Stevens; Deborah J Smyth; Neil M Walker; Kyla A Chandler; Polly J Bingley; John A Todd Journal: Diabetes Date: 2011-08-10 Impact factor: 9.461
Authors: Anna E Long; Kathleen M Gillespie; Rachel J Aitken; Julia C Goode; Polly J Bingley; Alistair J K Williams Journal: Diabetes Date: 2013-02-08 Impact factor: 9.461